<i>In vivo</i> scAAV-based NeuroD1 gene therapy inhibiting glioblastoma growth. [PDF]
Mazzetti D, Peruzzi PP, Soni H.
europepmc +1 more source
METTL14/IGF2BP-mediated m6A methylation of circSLIT2 promotes malignant phenotypes of glioblastoma via the miR-127-5p/SH3GLB1 axis. [PDF]
Wu L, Jin M, Chen L, Jiang Y, Wang F.
europepmc +1 more source
COPS7B Drives Malignant Progression of Glioblastoma Through Translational Upregulation of the Downstream Functional Effector CLU. [PDF]
Li J +8 more
europepmc +1 more source
SERPINI1 functions as a tumor suppressor in glioma. [PDF]
Luo S +8 more
europepmc +1 more source
Upregulated CircRNAs With Efficacy in Preclinical <i>In Vivo</i> Models Reveal New Targets for Therapeutic Intervention in Glioma. [PDF]
Nahkuri S, Weidle UH.
europepmc +1 more source
Magnetically actuated nanoantennas for wireless glioblastoma therapy. [PDF]
Saha M +9 more
europepmc +1 more source
<i>ZNF25</i> as an immunotherapy target: pan-cancer biomarker potential and mechanistic exploration in glioma. [PDF]
Yi X +9 more
europepmc +1 more source
Development of Surfactant-Modified Liposomal Lomustine to Improve Blood-Brain Barrier Transport and Therapeutic Outcomes in Glioblastoma. [PDF]
Rodponthukwaji K +6 more
europepmc +1 more source
Ubiquitin-Proteasome System-Related Prognostic Model and Immune Landscape in Glioblastoma. [PDF]
Huo D, Feng Y, Yu Z, Xie W, Jin H.
europepmc +1 more source
Correction: Ubiquitin-protein ligase E3C promotes glioma progression by mediating the ubiquitination and degrading of Annexin A7. [PDF]
Pan SJ +12 more
europepmc +1 more source

